麥哲倫油氣 MMP 深滬

交易中 08-10 10:37:25 美东时间

69.00

0.000

0.00%

華盛通

立即下載

最高--
今開--
成交量 0股
最低 --
昨收 69.00
總市值 1393.80万
52周最高 69.90
市盈率 ^靜 16.58
換手率 0.00%
52周最低 41.0836
委比 0.00%
總股本 0.00亿
歷史最高 69.90
量比 0
振幅 0.00%
歷史最低 7.2676
每手 1
風險率 0.21%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Magellan Aerospace declares $0.05 dividend

Magellan Aerospace (MALJF) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.69% Payable Sept. 29; for shareholders of record Sept. 15; ex-div Sept. 15. See MALJF Dividen...

今天 12:56
Magellan releases financial templates ahead of Barrenjoey merger consolidation

Magellan Financial Group Ltd ( ($AU:MFG) ) just unveiled an announcement. Magel...

今天 07:28
Magellanic Cloud Unit Wins ₹12.13 Crore Western Railway Surveillance Contract

An update from Magellanic Cloud Ltd. ( ($IN:MCLOUD) ) is now available. Magella...

08-06 12:43
Magellanic Cloud Subsidiary Wins $1.21 Million Google Orders, Boosting Growth Outlook

Magellanic Cloud Ltd. ( ($IN:MCLOUD) ) has issued an update. Magellanic Cloud L...

07-29 12:53
Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

Gain Therapeutics provided an update on its lead drug candidate, rexaceract, for Parkinson’s disease. The Phase 1b study showed safety, tolerability, and early signs of efficacy, with reductions in biomarkers like GluSph and clinical benefits observed. The company received IND authorization and plans to start a Phase 2 study in Q3 2026. Additionally, a second candidate, GT-04686, is advancing in preclinical development. The company also announced...

07-16 11:00
Positive Report for Magellan Financial Group Ltd (NNA) from Morgans

Magellan Financial Group Ltd received a Buy rating and an A$11.26 price target ...

07-13 09:05
Magellan Reports Lapse of Employee Equity and Incentive Securities

Magellan Financial Group Ltd ( ($AU:MFG) ) just unveiled an announcement. Magel...

07-10 09:07
Oryxium Loses Substantial Holder Status After Magellan–Barrenjoey Merger

Magellan Financial Group Ltd ( ($AU:MFG) ) has issued an update. Magellan Finan...

07-01 16:07
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Gain Therapeutics' GT-02287 has received FDA IND authorization, enabling Phase 2 clinical development in the U.S. for Parkinson's disease. Positive Phase 1 results showed target engagement, safety, and tolerability, with anecdotal improvements in symptoms. GT-02287, developed using Gain's Magellan AI platform, is the first allosteric modulator to achieve IND clearance. Phase 2 is expected to begin in 3Q26, involving sites in the U.S., Australia, ...

06-29 20:05

派息除權日	每股總股息	派息日期
2023-09-20	0.25	2023-09-25
2023-08-04	1.05	2023-08-14
2023-05-05	1.05	2023-05-15
2023-02-06	1.05	2023-02-14
2022-11-04	1.05	2022-11-14
2022-08-04	1.04	2022-08-12
2022-04-29	1.04	2022-05-13
2022-02-04	1.04	2022-02-14
2021-11-04	1.04	2021-11-12
2021-08-05	1.03	2021-08-13
2021-05-06	1.03	2021-05-14
2021-02-04	1.03	2021-02-12
2020-11-05	1.03	2020-11-13
2020-08-06	1.03	2020-08-14
2020-05-07	1.03	2020-05-15
2020-02-06	1.03	2020-02-14
2019-11-06	1.02	2019-11-14
2019-08-06	1.01	2019-08-14
2019-05-07	1.01	2019-05-15
2019-02-06	1.00	2019-02-14
2018-11-06	0.98	2018-11-14
2018-08-06	0.96	2018-08-14
2018-05-07	0.94	2018-05-15
2018-02-05	0.92	2018-02-14
2017-11-01	0.90	2017-11-14
2017-07-27	0.89	2017-08-14
2017-04-27	0.87	2017-05-15
2017-02-01	0.86	2017-02-14
2016-10-27	0.84	2016-11-14
2016-07-28	0.82	2016-08-12
2016-04-28	0.80	2016-05-13
2016-02-03	0.79	2016-02-12
2015-10-29	0.76	2015-11-13
2015-08-05	0.74	2015-08-14
2015-04-30	0.72	2015-05-15
2015-02-04	0.69	2015-02-13
2014-11-05	0.67	2014-11-14
2014-07-31	0.64	2014-08-14
2014-05-06	0.61	2014-05-15
2014-02-05	0.58	2014-02-14
2013-11-05	0.56	2013-11-14
2013-08-05	0.53	2013-08-14
2013-05-06	0.51	2013-05-15
2013-02-04	0.50	2013-02-14
2012-11-02	0.49	2012-11-14
2012-08-03	0.94	2012-08-14
2012-05-04	0.84	2012-05-15
2012-02-03	0.81	2012-02-14
2011-10-28	0.80	2011-11-14
2011-08-02	0.79	2011-08-12
2011-05-05	0.77	2011-05-13
2011-02-03	0.76	2011-02-14
2010-11-03	0.75	2010-11-12
2010-08-04	0.73	2010-08-13
2010-05-05	0.72	2010-05-14
2010-01-29	0.71	2010-02-12
2009-11-04	0.71	2009-11-13
2009-08-05	0.71	2009-08-14
2009-05-01	0.71	2009-05-15
2009-02-04	0.71	2009-02-13
2008-11-05	0.70	2008-11-14
2008-08-04	0.69	2008-08-14
2008-05-02	0.67	2008-05-15
2008-02-04	0.66	2008-02-14
2007-10-30	0.64	2007-11-14
2007-08-02	0.63	2007-08-14
2007-05-04	0.62	2007-05-15
2007-02-01	0.60	2007-02-14
2006-11-03	0.59	2006-11-14
2006-08-02	0.58	2006-08-14
2006-05-04	0.56	2006-05-15
2006-01-26	0.55	2006-02-14
2005-10-31	0.53	2005-11-14
2005-08-01	0.50	2005-08-12
2005-05-03	0.48	2005-05-13
2005-02-04	0.91	2005-02-14
2004-10-29	0.89	2004-11-12
2004-07-30	0.87	2004-08-13
2004-04-29	0.85	2004-05-14
2004-02-04	0.83	2004-02-13
2003-10-30	0.81	2003-11-14
2003-07-30	0.78	2003-08-14
2003-05-01	0.75	2003-05-15
2003-01-29	0.73	2003-02-14
2002-10-31	0.70	2002-11-14
2002-08-01	0.68	2002-08-14
2002-01-30	0.59	2002-02-14
2001-10-30	0.58	2001-11-14
2001-07-31	0.56	2001-08-14
2001-04-27	0.29	2001-05-15

公司名稱	麦哲伦油气
行業分類	--
業務描述	Magellan Midstream Partners LP engages in the transportation, storage, and distribution of petroleum products and crude oil. It operates through the following segments: Refined Products and Crude Oil. The Refined Products segment consists of an approximately 9,800-mile refined petroleum products pipeline system with 54 terminals and two marine storage terminals. The Crude Oil segment has approximately 2,200 miles of crude oil pipelines, a condensate splitter, and 39 million barrels of aggregate storage capacity, of which approximately 29 million barrels are used for contract storage. The company was founded in August 2000 and is headquartered in Tulsa, OK.

麥哲倫油氣 MMP 深 滬

69.00

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

麥哲倫油氣 MMP 深滬